• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绘制慢性皮肤病患者累积生命历程损伤风险因素图谱-系统综述。

Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases - a systematic review.

机构信息

German Center for Health Services Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

J Eur Acad Dermatol Venereol. 2021 Nov;35(11):2166-2184. doi: 10.1111/jdv.17348. Epub 2021 Jun 25.

DOI:10.1111/jdv.17348
PMID:33988873
Abstract

Patients with chronic skin diseases suffer from physical and psychosocial impairments which can lead to a cumulative life-long burden. Therefore, the concept of cumulative life course impairment (CLCI) was introduced, referring to the non-reversible damage due to the persistent life-long burden. This systematic review (PROSPERO registry number: CRD42020179141) aimed at mapping the risk factors and the associated burden over time in patients with psoriasis, atopic dermatitis (AD) and hidradenitis suppurativa (HS). Three electronic databases were searched (date of the last search: December 2019). Studies with a longitudinal study design that assessed the association between a risk factor and the associated burden over time in patients with psoriasis, AD and HS were included. Quality assessment of the included studies was done using Critical Appraisal Skills Programme (CASP) checklists. In total, 40 publications reflecting 25 different studies were included: nine studies addressed patients with psoriasis, 13 patients with AD, two studies included patients with HS and one study enrolled patients with psoriasis and AD, respectively. Twenty-two potential risk factors with underlying evidence were found in this review. These risk factors include mainly sociodemographic (such as age or gender) and clinical (such as disease severity or comorbidities) variables. Disease severity and comorbidities were the most often studied risk factors, while only a few studies evaluated psychosocial risk factors over time. Patients with chronic skin diseases are at high risk to develop a life-long negative impact from the disease. However, there is a lack of data that evaluates the psychosocial burden and its influence on the patients' life course over time. The risk factors found in this review help to identify patients at risk, to treat them adequately and, ultimately, to prevent CLCI. These results can be the basis to develop a highly needed tool to assess the risk for CLCI in the future.

摘要

患有慢性皮肤病的患者会受到身体和心理社会方面的损伤,这些损伤可能会导致终身的累积负担。因此,引入了累积生命过程损伤(CLCI)的概念,指的是由于持续的终身负担而造成的不可逆转的损伤。本系统评价(PROSPERO 注册号:CRD42020179141)旨在绘制银屑病、特应性皮炎(AD)和化脓性汗腺炎(HS)患者的风险因素及其随时间推移的相关负担。共检索了三个电子数据库(最后检索日期:2019 年 12 月)。本研究纳入了采用纵向研究设计、评估患者银屑病、AD 和 HS 中风险因素与相关负担随时间变化的关联的研究。采用批判性评估技巧方案(CASP)检查表对纳入研究进行质量评估。共纳入 40 篇文献,反映了 25 项不同的研究:9 项研究涉及银屑病患者,13 项研究涉及 AD 患者,2 项研究包括 HS 患者,1 项研究分别纳入了银屑病和 AD 患者。本综述发现了 22 个具有潜在证据的潜在风险因素。这些风险因素主要包括社会人口统计学(如年龄或性别)和临床(如疾病严重程度或合并症)变量。疾病严重程度和合并症是研究最多的风险因素,而只有少数研究随时间评估了心理社会风险因素。患有慢性皮肤病的患者有很高的风险会因疾病而产生终身的负面影响。然而,目前缺乏评估心理社会负担及其对患者生活轨迹随时间推移的影响的数据。本综述中发现的风险因素有助于识别处于风险中的患者,对其进行充分治疗,并最终预防 CLCI。这些结果可以为未来开发评估 CLCI 风险的高度需要的工具提供基础。

相似文献

1
Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases - a systematic review.绘制慢性皮肤病患者累积生命历程损伤风险因素图谱-系统综述。
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):2166-2184. doi: 10.1111/jdv.17348. Epub 2021 Jun 25.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
3
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
4
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.使用比美吉珠单抗治疗化脓性汗腺炎的III期BE HEARD I和II试验的汇总数据,对化脓性汗腺炎生活质量(HiSQOL©)问卷进行心理测量学验证和解释阈值分析。
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.特应性皮炎和银屑病的疾病严重程度定义:应用于生物标志物研究的跨学科视角。
Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080.

引用本文的文献

1
Impact of Alopecia Areata on Major Life-changing Decisions: Prevalence and Associated Factors.斑秃对重大生活决策的影响:患病率及相关因素
Acta Derm Venereol. 2025 Sep 10;105:adv43039. doi: 10.2340/actadv.v105.43039.
2
Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach.特应性皮炎和银屑病患者生活质量的决定因素:一种多变量方法。
Acta Derm Venereol. 2025 May 19;105:adv42794. doi: 10.2340/actadv.v105.42794.
3
Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study.
瑞莎珠单抗在对司库奇尤单抗或依奇珠单抗反应欠佳的银屑病患者中的疗效和安全性:一项3b期、开放标签、单臂(aIMM)研究的结果
Dermatol Ther (Heidelb). 2024 Dec;14(12):3273-3290. doi: 10.1007/s13555-024-01292-z. Epub 2024 Nov 8.
4
Interventions to Reduce Skin-related Self-stigma: A Systematic Review.减少皮肤相关自我污名化的干预措施:系统评价。
Acta Derm Venereol. 2024 Sep 10;104:adv40384. doi: 10.2340/actadv.v104.40384.
5
A Qualitative Exploration of the Impact, Management, and Existing Psychological Support Available for Adults Living with Skin Conditions.成人皮肤病患者的影响、管理及现有心理支持的定性探索
Acta Derm Venereol. 2024 Aug 23;104:adv40657. doi: 10.2340/actadv.v104.40657.
6
Structural and functional imaging of psoriasis for severity assessment and quantitative monitoring of treatment response using high-resolution optoacoustic imaging.利用高分辨率光声成像对银屑病进行结构和功能成像,以评估严重程度并定量监测治疗反应。
Photoacoustics. 2024 Apr 23;38:100611. doi: 10.1016/j.pacs.2024.100611. eCollection 2024 Aug.
7
Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G-EPOSS study.在常规临床实践中,古塞库单抗对银屑病患者性功能及感知耻辱感的有效性、安全性和影响:德国前瞻性多中心G-EPOSS研究第28周结果
J Eur Acad Dermatol Venereol. 2025 Mar;39 Suppl 1(Suppl 1):15-26. doi: 10.1111/jdv.19927. Epub 2024 Apr 11.
8
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.特应性皮炎和银屑病的疾病严重程度定义:应用于生物标志物研究的跨学科视角。
Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080.
9
Cumulative life course impairment in patients with dermatological diseases, with a focus on psoriasis.皮肤科疾病患者的累积生命历程损伤,重点关注银屑病。
An Bras Dermatol. 2024 Mar-Apr;99(2):269-276. doi: 10.1016/j.abd.2023.08.006. Epub 2023 Dec 21.
10
Factors Influencing Major Life-Changing Decisions in Patients with Psoriasis: A Cross-sectional Study.影响银屑病患者重大生活改变决策的因素:一项横断面研究。
Acta Derm Venereol. 2023 Oct 10;103:adv11640. doi: 10.2340/actadv.v103.11640.